---
title: "Gut Microbiome Biomarkers Associated with Primary VT/VF in STEMI Identified by Machine Learning"
id: "medrxiv-22-machine-learning-approach-to-identify-gut-microbiota-biomarkers-in-patients"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-22-machine-learning-approach-to-identify-gut-microbiota-biomarkers-in-patients"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.16.26363271v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Gut Microbiome Biomarkers Associated with Primary VT/VF in STEMI Identified by Machine Learning
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-22-machine-learning-approach-to-identify-gut-microbiota-biomarkers-in-patients
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.16.26363271v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This study used full-length 16S rRNA sequencing and a machine learning (ML) pipeline to identify gut microbial taxa and predicted metabolic pathways associated with **primary VT/VF** in patients with **ST-elevation myocardial infarction (STEMI)**. - Stool samples were collected from 33 STEMI patients: 7 with primary VT/VF and 26 without VT/VF, sampled during the acute phase (≤7 days) and the recovery phase (30–60 days). - Core biomarkers required both univariate significance (FDR <0.05) and multivariate importance in classification models. - Five acute-phase taxa reproducibly associated with primary VT/VF were identified: **Clostridium aldenense**, **Enterocloster bolteae**, bacterium NLAE-zl-G101, **Alistipes shahii**, and **Roseburia** sp. - Differential abundance analysis additionally found enrichment of **Bacteroides fragilis**, **Bacteroides thetaiotaomicron**, and **E. bolteae** in patients with primary VT/VF. - A reduced-feature support vector machine classifier based on identified taxa achieved an AUC of 0.846 (95% CI 0.676–0.984), with sensitivity 85.7% and specificity 76.9% in distinguishing patients with primary VT/VF. - Functional prediction with PICRUSt2 suggested enrichment of metabolic functions related to **fucose degradation** and **purine catabolism**, including predicted increases in L-fucose mutarotase and xanthine dehydrogenase. - The gut microbial signature described includes Lachnoclostridium-related taxa, persistent Bacteroides enrichment, and enhanced predicted fucose and purine metabolism. - The authors emphasize these are exploratory findings that require validation in larger, independent cohorts and mechanistic studies; no competing interests were declared and IRB approval and informed consent were obtained. - Data are available from the corresponding author upon reasonable request, subject to institutional and ethical restrictions.
## Clinical Analysis & Structured Key Points
Machine Learning Approach to Identify Gut Microbiota Biomarkers in Patients with ST-Elevation Myocardial Infarction Presenting Primary Ventricular Tachyarrhythmias | medRxiv Skip to main content Machine Learning Approach to Identify Gut Microbiota Biomarkers in Patients with ST-Elevation Myocardial Infarction Presenting Primary Ventricular Tachyarrhythmias Hsu-Po Tseng , Zi-Lun Lai , Yi-Yao Hsu , Yuan-Hua Hung , View ORCID Profile Der-Yang Cho , Po-Ren Hsueh , View ORCID Profile Wei-Hsin Chung , View ORCID Profile Mei-Yao Wu , View ORCID Profile Yen-Nien Lin , View ORCID Profile Ke-Wei Chen , View ORCID Profile Shih-Sheng Chang , View ORCID Profile Kuan-Cheng Chang doi: https://doi.org/10.64898/2026.09.16.26363271 Hsu-Po Tseng 1 China Medical University School of Medicine, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Zi-Lun Lai 2 China Medical University Hospital Health System, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yi-Yao Hsu 2 China Medical University Hospital Health System, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yuan-Hua Hung 2 China Medical University Hospital Health System, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Der-Yang Cho 3 1.China Medical University Hospital 2.China Medical University, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Der-Yang Cho Po-Ren Hsueh 4 China Medical University Hospital, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Wei-Hsin Chung 5 China Medical University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Wei-Hsin Chung Mei-Yao Wu 4 China Medical University Hospital, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mei-Yao Wu Yen-Nien Lin 6 Cedars-Sinai Medical Center, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Yen-Nien Lin Ke-Wei Chen 4 China Medical University Hospital, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ke-Wei Chen Shih-Sheng Chang 4 China Medical University Hospital, TAIWAN; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Shih-Sheng Chang Kuan-Cheng Chang 7 Superintendent of Taichung Municipal Geriatric Rehabilitation General Hospital, TAIWAN Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Kuan-Cheng Chang For correspondence: kuancheng.chang{at}gmail.com Abstract Info/History Metrics Data/Code Preview PDF Abstract Background Risk stratification for primary ventricular tachycardia/ventricular fibrillation (VT/VF) in patients with ST-elevation myocardial infarction (STEMI) remains limited. We aimed to identify gut microbiome biomarkers and microbial metabolic pathways associated with primary VT/VF in STEMI using machine learning (ML). Methods Stool samples from 33 STEMI patients (7 with primary VT/VF and 26 without VT/VF) underwent full-length 16S rRNA sequencing during the acute (≤7 days) and recovery (30?60 days) phases. An ML pipeline integrating taxonomic features identified reproducible features associated with primary VT/VF. Core biomarkers were defined as taxa demonstrating both univariate significance (false discovery rate [FDR] <0.05) and multivariate classification importance. Functional pathways and enzymes were predicted using PICRUSt2. Results Five acute-phase taxa were reproducibly associated with primary VT/VF: Clostridium aldenense, Enterocloster bolteae, bacterium NLAE-zl-G101, Alistipes shahii, and Roseburia sp. (all FDR <0.05). A reduced-feature support vector machine model achieved an area under the receiver operating characteristic curve of 0.846 (95% confidence interval, 0.676?0.984), with 85.7% sensitivity and 76.9% specificity. Differential abundance analysis showed enrichment of Bacteroides fragilis, Bacteroides thetaiotaomicron, and E. bolteae. Functional analysis demonstrated enrichment of fucose degradation and purine catabolism, with increased predicted abundances of L-fucose mutarotase and xanthine dehydrogenase. Conclusions Primary VT/VF in STEMI was associated with a distinct gut microbiome-metabolic signature characterized by Lachnoclostridium-related taxa, persistent Bacteroides enrichment, and enhanced predicted fucose and purine metabolism. These exploratory findings warrant validation in larger independent cohorts and mechanistic studies. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of China Medical University Hospital (CMUH111-REC3-195). Written informed consent was obtained from all participants prior to enrollment. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data that support the findings of this study are available from the corresponding author upon reasonable request, subject to institutional and ethical restrictions governing participant data. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Machine Learning Approach to Identify Gut Microbiota Biomarkers in Patients with ST-Elevation Myocardial Infarction Presenting Primary Ventricular Tachyarrhythmias Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Machine Learning Approach to Identify Gut Microbiota Biomarkers in Patients with ST-Elevation Myocardial Infarction Presenting Primary Ventricular Tachyarrhythmias Hsu-Po Tseng , Zi-Lun Lai , Yi-Yao Hsu , Yuan-Hua Hung , Der-Yang Cho , Po-Ren Hsueh , Wei-Hsin Chung , Mei-Yao Wu , Yen-Nien Lin , Ke-Wei Chen , Shih-Sheng Chang , Kuan-Cheng Chang medRxiv 2026.09.16.26363271; doi: https://doi.org/10.64898/2026.09.16.26363271 Share This Article: Copy Citation Tools Machine Learning Approach to Identify Gut Microbiota Biomarkers in Patients with ST-Elevation Myocardial Infarction Presenting Primary Ventricular Tachyarrhythmias Hsu-Po Tseng , Zi-Lun Lai , Yi-Yao Hsu , Yuan-Hua Hung , Der-Yang Cho , Po-Ren Hsueh , Wei-Hsin Chung , Mei-Yao Wu , Yen-Nien Lin , Ke-Wei Chen , Shih-Sheng Chang , Kuan-Cheng Chang medRxiv 2026.09.16.26363271; doi: https://doi.org/10.64898/2026.09.16.26363271 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (618) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4825) Dentistry and Oral Medicine (479) Dermatology (418) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15966) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7060) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5058) Health Policy (1436) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16302) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7290) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3613) Ophthalmology (1054) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (738) Primary Care Research (768) Psychiatry and Clinical Psychology (5915) Public and Global Health (9769) Radiology and Imaging (2430) Rehabilitation Medicine and Physical Therapy (1455) Respiratory Medicine (1249) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (578) Surgery (781) Toxicology (107) Transplantation (305) Urology (292)
## Related Clinical Research

- [Retinal changes on OCT may predict atrial fibrillation risk years before diagnosis](https://medichelpline.com/clinical-feed/medical-news-today-0-how-changes-in-the-eyes-may-help-spot-afib-risk-years-early.md)
- [Dyslipidemia care in Japan before and after the 2024 fee revision: nationwide claims analysis](https://medichelpline.com/clinical-feed/plos-one-19-real-world-patterns-of-dyslipidemia-care-before-and-after-a-national-fee.md)
- [Rotating Night Shift Work and Cardiovascular Disease and Mortality Risk by Chronotype in Nurses' H](https://medichelpline.com/clinical-feed/medrxiv-9-rotating-night-shift-work-and-risk-of-incident-cardiovascular-disease-and.md)
- [MGST3 marks a mitochondrial-health–linked M2-like macrophage state in atherosclerosis](https://medichelpline.com/clinical-feed/frontiers-in-immunology-7-mgst3-defines-a-mitochondrial-health-associated-m2-macrophage-state-in.md)
- [Sex-Asymmetric Cardiometabolic Risk Trends in Young Adults Across 16 MENA Countries (1990–2018)](https://medichelpline.com/clinical-feed/medrxiv-3-cardiometabolic-risk-trajectories-in-young-adults-across-16-middle-east-and.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.